Northpond Ventures, LLC Candel Therapeutics, Inc. Put Options Transaction History
Northpond Ventures, LLC
- $27.7 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CADL
# of Institutions
82Shares Held
15.7MCall Options Held
536KPut Options Held
335K-
Baker Bros. Advisors LP New York, NY2.44MShares$14.7 Million0.16% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.15MShares$13 Million8.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.79MShares$10.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA904KShares$5.44 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA881KShares$5.3 Million0.41% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $174M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...